NCT02073994 2026-02-17Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 MutationServierPhase 1 Completed174 enrolled
NCT04278781 2025-10-23AG-120 in People With IDH1 Mutant ChondrosarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting6 enrolled